Viewing Study NCT02858492


Ignite Creation Date: 2025-12-24 @ 3:25 PM
Ignite Modification Date: 2026-01-29 @ 7:52 AM
Study NCT ID: NCT02858492
Status: COMPLETED
Last Update Posted: 2021-06-15
First Post: 2016-07-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficacy of Repeat Doses of GSK2982772 in Subjects With Moderate to Severe Rheumatoid Arthritis (RA)
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 203168
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators